Switzerland: Adults with type 1 diabetes using CGM and a smart insulin pen achieved higher time in range when they ...

Ozempic, the globally sought-after semaglutide injection that has dominated conversations around diabetes care and weight loss, has finally entered the Indian market. With it, an immediate surge of ...

For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...

The global gestational diabetes market size was valued at USD 9.44 billion in 2024 and is predicted to hit around USD 22.58 ...

Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

For patients with diabetes, the days after hospital discharge can be as risky as the days leading up to admission. Clinicians ...

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...

With India facing over 101 million cases of diabetes and rising obesity levels, the drug could play a significant role in ...

Ozempic, the blockbuster weight-loss drug by Novo Nordisk, was launched in India on Friday (December 12). In India, the drug will be marketed for adults with type-2 diabetes, unlike in the US and ...

While Ozempic offers proven benefits for blood sugar control, weight management, and cardiovascular protection, its arrival ...

Looking to expand its footprint in the booming glucagon-like peptide (GLP-1) market, Danish drugmaker Novo Nordisk has ...